Annovis Bio, Inc.

NYSE:ANVS

Biotechnology

Healthcare
$1.21 +0.00%

+$0.00 today

Market cap
$51.64M
Beta
1.24
P/E (TTM)
-1.1
EPS (TTM)
-$1.47
52W Low $1.54High $5.50

Volume 1.35M

Average 1.08M

Price history

Annovis Bio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-68.81%

Period high

$5.10

Period low

$1.18

Latest

$1.21

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
DEF 14ASep 11, 2026Sep 11, 2026
PRE 14AAug 25, 2026Aug 24, 2026
10-QAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
8-KAug 14, 2026Aug 14, 2026
SC 13GJul 29, 2026Jul 29, 2026
8-KJul 10, 2026Jul 9, 2026
8-KJun 17, 2026Jun 17, 2026
4May 21, 2026May 21, 2026
8-KMay 20, 2026May 20, 2026
424B5May 20, 2026May 20, 2026
424B5May 19, 2026May 19, 2026
8-KMay 15, 2026May 15, 2026
10-QMay 15, 2026May 15, 2026
DEF 14AApr 30, 2026Apr 30, 2026

Competitors

Who does Annovis Bio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ANVS's filings, answered from its disclosures.

What is the latest ANVS filing?

The latest filing shown is DEF 14A dated Sep 11, 2026.

How many recent filings does ANVS have?

Intrinsic Alpha currently shows 20 recent filings for ANVS.